Pacira BioSciences (PCRX) Stock Chart & Stock Price History → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free PCRX Stock Alerts $29.86 +0.21 (+0.71%) (As of 05/9/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Pacira BioSciences Stock Price Performance5 Day Performance+9.74%1 Month Performance+7.29%3 Month Performance+3.75%6 Month Performance+4.85%Year-To-Date Performance-11.50%1 Year Performance-30.38% Receive PCRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. PCRX Stock Chart for Friday, May, 10, 2024 PCRX Chart by TradingView Pacira BioSciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/09/2024$29.65$29.86+0.71%$30.48$28.902.35 million shs$1.39 billion05/08/2024$26.51$29.65+11.84%$30.58$28.281.96 million shs$1.38 billion05/07/2024$26.50$26.51+0.04%$27.27$26.43734,463 shs$1.23 billion05/06/2024$27.21$26.50-2.61%$27.86$26.47733,744 shs$1.23 billion05/03/2024$27.32$27.21-0.40%$27.77$27.05247,305 shs$1.27 billion05/02/2024$26.95$27.32+1.37%$27.40$26.65340,710 shs$1.27 billion Get the Latest News and Ratings for PCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. 05/01/2024$26.25$26.95+2.67%$27.12$26.28449,862 shs$1.25 billion04/30/2024$26.05$26.25+0.77%$26.31$25.44479,672 shs$1.22 billion04/29/2024$26.33$26.05-1.06%$26.71$26.04540,323 shs$1.21 billion04/26/2024$25.50$26.33+3.25%$26.37$25.33304,606 shs$1.22 billion04/25/2024$25.90$25.50-1.54%$26.00$25.33305,832 shs$1.19 billion04/24/2024$26.81$25.90-3.39%$26.77$25.78359,410 shs$1.20 billion04/23/2024$26.10$26.81+2.72%$27.08$26.19497,168 shs$1.25 billion04/22/2024$26.25$26.10-0.57%$26.67$25.74375,229 shs$1.21 billion04/19/2024$26.10$26.25+0.57%$26.34$25.91448,972 shs$1.22 billion04/18/2024$26.77$26.10-2.50%$26.84$26.08621,147 shs$1.21 billion04/17/2024$26.87$26.77-0.37%$27.13$26.36415,509 shs$1.24 billion04/16/2024$26.53$26.87+1.28%$27.63$26.29721,372 shs$1.25 billion04/15/2024$26.83$26.53-1.12%$27.04$25.76604,436 shs$1.23 billion04/12/2024$27.36$26.83-1.94%$27.29$26.61471,620 shs$1.25 billion04/11/2024$27.83$27.36-1.69%$28.09$27.22323,567 shs$1.27 billion04/10/2024$28.52$27.83-2.42%$28.36$27.52444,858 shs$1.33 billion04/09/2024$28.48$28.52+0.14%$28.84$27.99363,923 shs$1.33 billion04/08/2024$28.16$28.48+1.14%$28.73$28.10326,413 shs$1.32 billion04/05/2024$28.40$28.16-0.85%$28.45$27.94415,395 shs$1.31 billion04/04/2024$29.01$28.40-2.10%$29.47$28.18403,192 shs$1.32 billion04/03/2024$28.51$29.01+1.75%$29.12$28.26307,484 shs$1.35 billion04/02/2024$29.15$28.51-2.20%$29.17$28.31477,020 shs$1.33 billion04/01/2024$29.22$29.15-0.24%$29.44$28.43335,223 shs$1.36 billion03/29/2024$29.22$29.22$29.58$28.86569,631 shs$1.36 billion03/28/2024$29.04$29.22+0.62%$29.58$28.86569,630 shs$1.36 billion03/27/2024$28.51$29.04+1.86%$29.30$28.36556,686 shs$1.35 billion03/26/2024$29.23$28.51-2.46%$29.48$28.25531,748 shs$1.33 billion03/25/2024$28.67$29.23+1.95%$29.40$28.60383,010 shs$1.36 billion03/22/2024$29.29$28.67-2.12%$29.45$28.44360,010 shs$1.33 billion03/21/2024$30.02$29.29-2.43%$30.39$29.22535,711 shs$1.36 billion03/20/2024$29.47$30.02+1.87%$30.16$29.08276,537 shs$1.40 billion03/19/2024$29.29$29.47+0.61%$29.72$28.87287,318 shs$1.37 billion03/18/2024$29.41$29.29-0.41%$29.62$28.70327,985 shs$1.36 billion03/15/2024$29.26$29.41+0.51%$29.68$28.821.26 million shs$1.37 billionYou need to know these two things about AI stocks ASAP… (Ad)For 40 years, he's been known as one of the world's most bullish investors. Forbes even referred to him a "perma bull"... But he just shocked the world by issuing a massive bear warning about AI stocks.Go here now for this breaking story.03/14/2024$30.29$29.26-3.40%$30.27$29.11440,057 shs$1.36 billion03/13/2024$30.56$30.29-0.88%$30.95$29.89369,964 shs$1.41 billion03/12/2024$31.02$30.56-1.48%$31.46$30.51260,206 shs$1.42 billion03/11/2024$31.41$31.02-1.24%$31.45$30.83438,364 shs$1.44 billion03/08/2024$30.64$31.41+2.51%$31.43$30.35527,815 shs$1.46 billion03/07/2024$30.11$30.64+1.76%$31.47$30.25626,719 shs$1.42 billion03/06/2024$29.44$30.11+2.28%$30.16$28.96605,390 shs$1.40 billion03/05/2024$29.20$29.44+0.82%$29.45$28.62452,611 shs$1.37 billion03/04/2024$28.86$29.20+1.18%$29.49$27.89711,605 shs$1.36 billion03/01/2024$29.72$28.86-2.89%$30.00$28.68643,001 shs$1.34 billion02/29/2024$29.91$29.72-0.64%$30.52$28.61768,356 shs$1.38 billion02/28/2024$29.85$29.91+0.20%$30.26$29.30540,621 shs$1.39 billion02/27/2024$29.74$29.85+0.37%$30.20$29.67497,562 shs$1.39 billion02/26/2024$30.04$29.74-1.00%$30.10$29.56351,727 shs$1.39 billion02/23/2024$29.97$30.04+0.23%$30.34$29.46348,523 shs$1.40 billion02/22/2024$29.70$29.97+0.91%$29.98$29.36358,313 shs$1.39 billion02/21/2024$29.86$29.70-0.54%$29.96$29.52299,858 shs$1.38 billion02/20/2024$29.08$29.86+2.68%$29.88$28.86401,451 shs$1.39 billion02/19/2024$29.08$29.08$29.81$29.08350,000 shs$1.35 billion02/16/2024$29.66$29.08-1.96%$29.81$29.08350,012 shs$1.35 billion02/15/2024$29.23$29.66+1.47%$29.93$29.37286,786 shs$1.38 billion02/14/2024$29.21$29.23+0.07%$29.65$29.00286,688 shs$1.36 billion02/13/2024$30.02$29.21-2.70%$29.91$28.94360,643 shs$1.36 billion02/12/2024$28.78$30.02+4.31%$30.04$28.92644,664 shs$1.39 billion02/09/2024$27.70$28.78+3.90%$28.97$27.66604,019 shs$1.34 billion Related Companies: Supernus Pharmaceuticals Stock Chart Agios Pharmaceuticals Stock Chart ADC Therapeutics Stock Chart Atea Pharmaceuticals Stock Chart Nektar Therapeutics Stock Chart Seres Therapeutics Stock Chart Corcept Therapeutics Stock Chart Alkermes Stock Chart Perrigo Stock Chart Spyre Therapeutics Stock Chart Receive PCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PCRX) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaProof that the Musk/Bezos rivalry is about to hit a new levelInvestorPlaceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap Profits[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacira BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.